169 related articles for article (PubMed ID: 20082194)
1. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.
Hioki M; Gotohda N; Konishi M; Nakagohri T; Takahashi S; Kinoshita T
World J Surg; 2010 Mar; 34(3):555-62. PubMed ID: 20082194
[TBL] [Abstract][Full Text] [Related]
2. Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis.
Li S; Lan X; Gao H; Wang W; Chen L; Song S; Xue Y
Tumour Biol; 2017 Jun; 39(6):1010428317697567. PubMed ID: 28618957
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
Kobayashi H; Honda M; Kawamura H; Takiguchi K; Muto A; Yamazaki S; Teranishi Y; Shiraso S; Kono K; Hori S; Kamiga T; Iwao T; Yamashita N
J Surg Oncol; 2022 Mar; 125(4):615-620. PubMed ID: 34985764
[TBL] [Abstract][Full Text] [Related]
4. A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.
Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Nishikawa T; Tanaka J; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Ishihara S; Sunami E; Watanabe T
J Med Case Rep; 2016 Jan; 10():14. PubMed ID: 26786355
[TBL] [Abstract][Full Text] [Related]
5. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
[TBL] [Abstract][Full Text] [Related]
6. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.
Geng X; Liu H; Lin T; Hu Y; Chen H; Zhao L; Mou T; Qi X; Yu J; Li G
Cancer Med; 2016 Oct; 5(10):2781-2791. PubMed ID: 27650694
[TBL] [Abstract][Full Text] [Related]
8. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
[TBL] [Abstract][Full Text] [Related]
9. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
[TBL] [Abstract][Full Text] [Related]
10. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.
Shim HJ; Kim HJ; Lee SH; Bae WK; Hwang EC; Cho SH; Chung IJ; Bang HJ; Hwang JE
Sci Rep; 2020 Jun; 10(1):9549. PubMed ID: 32533084
[TBL] [Abstract][Full Text] [Related]
11. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
12. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK; Ji J; Han SU; Terashima M; Li G; Kim HH; Law S; Shabbir A; Song KY; Hyung WJ; Kosai NR; Kono K; Misawa K; Yabusaki H; Kinoshita T; Lau PC; Kim YW; Rao JR; Ng E; Yamada T; Yoshida K; Park DJ; Tai BC; So JBY;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):120-127. PubMed ID: 33253659
[TBL] [Abstract][Full Text] [Related]
13. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
Boerner T; Graichen A; Jeiter T; Zemann F; Renner P; März L; Soeder Y; Schlitt HJ; Piso P; Dahlke MH
Ann Surg Oncol; 2016 Nov; 23(12):3972-3977. PubMed ID: 27313067
[TBL] [Abstract][Full Text] [Related]
14. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
16. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
Komatsu S; Shioaki Y; Furuke H; Ohta A; Tsuji R; Tanaka S; Kumano T; Imura KI; Shimomura K; Ikeda J; Taniguchi F; Ueshima Y; Lee CJ; Deguchi E; Ikeda E; Otsuji E
Langenbecks Arch Surg; 2019 Aug; 404(5):599-604. PubMed ID: 31073759
[TBL] [Abstract][Full Text] [Related]
17. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
18. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
19. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.
Allen CJ; Blumenthaler AN; Das P; Minsky BD; Blum M; Roy-Chowdhuri S; Ajani JA; Ikoma N; Mansfield PF; Badgwell BD
World J Surg Oncol; 2020 Feb; 18(1):39. PubMed ID: 32066454
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
